Yahoo Web Search

Search results

    • Why Moderna Stock Is a No-Brainer Buy Right Now

      The Motley Fool via AOL· 5 days ago

      In 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only $4 billion this year. The real story for Moderna is much better than that ...